Travel Health

Manson's Tropical Diseases, Twenty-second Edition

Volumn , Issue , 2008, Pages 515-525

  Behrens, Ronald H ^a   Steffen, Robert ^b,c  

^a HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^b WHO Collaborating Centre for Travellers' Health   (Switzerland)

^c UNIVERSITY OF ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 85158993749     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1016/B978-1-4160-4470-3.50032-X     Document Type: Chapter

References (56)

1. SW Hargarten, TD Baker and K Guptill (1991) Overseas fatalities of United States citizen travelers: an analysis of deaths related to international travel 2. Ann Emerg Med 20 622-626.
2. E Nordberg (2000) Injuries as a public health problem in sub-Saharan Africa: epidemiology and prospects for control. East Afr Med J 77(12 Suppl), S1-S43.
3. E Petridou, H Askitopoulou, D Vourvahakis, et al. (1997) Epidemiology of road traffic accidents during pleasure travelling: the evidence from the Island of Crete. Accid Anal Prev 29 687-693.
4. Centers for Disease Control and Prevention (CDC) (1993) Alcohol use and aquatic activities - United States, 1991. MMWR Morb Mortal Wkly Rep 42 681-683.
5. S Hawkes, GJ Hart, AM Johnson, et al. (1994) Risk behaviour and HIV prevalence in international travellers. AIDS 8 247-252.
6. B Hogh, PD Clarke, D Camus, et al. (2000) Atovaquone-proguanil versus chloroquine-proguanil for malaria prophylaxis in non-immune travellers: a randomised, double-blind study. Lancet 356 1888-1894.
7. D Overbosch, H Schilthuis, U Bienzle, et al. (2001) Atovaquone-proguanil versus mefloquine for malaria prophylaxis in nonimmune travelers: results from a randomized, double-blind study. Clin Infect Dis 33 1015-1021.
8. F von Sonnenburg, NG Tornieporth, P Waiyaki, et al. (2000) Risk and aetiology of diarrhoea at various tourist destinations. Lancet 356 133-134.
9. B Pitzinger, R Steffen and A Tschopp (1991) Incidence and clinical features of travelers' diarrhea in infants and children. Pediatr Infect Dis J 10 719-723.
10. R Steffen, F Collard, N Tornieporth, et al. (1999) Epidemiology, aetiology and impact of travellers' diarrhea in Jamaica. JAMA 281 811-817.
11. E Stermer, A Lubezky, I Potasman, et al. (2006) Is traveler's diarrhea a significant risk factor for the development of irritable bowel syndrome? A prospective study. Clin Infect Dis 43 898-901.
12. H Gomi, ZD Jiang, JA Adachi, et al. (2001) In vitro antimicrobial susceptibility testing of bacterial enteropathogens causing traveler's diarrhea in four geographic regions. Antimicrob Agents Chemother 45 212-216.
13. ZD Jiang, B Lowe, MP Verenkar, et al. (2002) Prevalence of enteric pathogens among international travelers with diarrhea acquired in Kenya (Mombasa), India (Goa), or Jamaica (Montego Bay). J Infect Dis 185 497-502.
14. CD Ericsson (1998) Travelers' diarrhea: epidemiology, prevention and self-treatment. Infect Dis Clin North Am 12 285-303.
15. L Mattila, A Siitonen and H Kyronseppa (1995) Risk behaviour for travelers' diarrhea among Finnish travelers. J Trav Med 2 77-84.
16. HL DuPont and CD Ericsson (1993) Prevention and treatment of travelers' diarrhea. N Engl J Med 328 1821-1827.
17. HL DuPont, ZD Jiang, PC Okhuysen, et al. (2005) A randomized, double-blind, placebo-controlled trial of rifaximin to prevent travelers' diarrhea. Ann Intern Med 142 805-812.
18. H Peltola, A Siitonen, H Kyronseppa, et al. (1991) Prevention of travellers' diarrhoea by oral B-subunit/whole-cell cholera vaccine. Lancet 338 1285-1289.
19. D Wingate, SF Phillips, SJ Lewis, et al. (2001) Guidelines for adults on self-medication for the treatment of acute diarrhoea. Aliment Pharmacol Ther 15 773-782.
20. L Mattila (1994) Clinical features and duration of travelers' diarrhea in relation to its etiology. Clin Infect Dis 19 728-734.
21. G De Bruyn, S Hahn and A Borwick (2000) Antibiotic treatment for travellers' diarrhoea (Cochrane review). Cochrane Database Syst Rev (3), CD002242.
22. R Steffen (1990) Worldwide efficacy of bismuth subsalicylate in the treatment of travelers' diarrhea. Rev Infect Dis 12(suppl 1), S80-S86.
23. HL DuPont, CD Ericsson, JJ Mathewson, et al. (1998) Rifaximin: a nonabsorbed antimicrobial in the therapy of travelers' diarrhea. Digestion 59 708-714.
24. P Muentener, P Schlagenhauf and R Steffen (1999) Imported malaria (1985-95): trends and perspectives. Bull World Health Organ 77 560-566.
25. RH Behrens, Z Bisoffi, A Björkman, et al. (2006) Malaria prophylaxis policy for travellers from Europe to the Indian Subcontinent. Malar J 5 1-7.
26. SI Hay, DJ Rogers, JF Toomer, et al. (2000) Annual Plasmodium falciparum entomological inoculation rates (EIR) across Africa: literature survey, internet access and review. Trans R Soc Trop Med Hyg 94 113-127.
27. LC Rutledge, RK Gupta, ZA Mehr, et al. (1996) Evaluation of controlled-release mosquito repellent formulations. J Am Mosq Control Assoc 12 39-44.
28. A Schoepke, R Steffen and N Gratz (1998) Effectiveness of personal protection measures against mosquito bites for malaria prophylaxis in travellers. J Trav Med 5 188-192.
29. CR Meier, K Wilcock and SS Jick (2004) The risk of severe depression, psychosis or panic attacks with prophylactic antimalarials. Drug Saf 27 203-213.
30. C Ohrt, TL Richie, H Widjaja, et al. (1997) Mefloquine compared with doxycycline for the prophylaxis of malaria in Indonesian soldiers. A randomised, double-blind, placebo-controlled trial. Ann Intern Med 126 963-972.
31. P Frost, GD Weinstein and EC Gomez (1972) Phototoxic potential of minocycline and doxycycline. Arch Dermatol 105 681-683.
32. M Schuhwerk and RH Behrens (1998) Doxycycline as first line malarial prophylaxis: how safe is it? J Trav Med 5 102.
33. GD Shanks, PG Kremsner, TY Sukwa, et al. (1999) Atovaquone and proguanil hydrochloride for the chemoprophylaxis of malaria. J Trav Med 6(suppl 1), S21-S27.
34. DR Hill, JK Baird, ME Parise, et al. (2006) Primaquine: report from CDC expert meeting on malaria chemoprophylaxis I. Am J Trop Med Hyg 75 402-415.
35. WHO (2001) International Travel and Health Geneva: World Health Organization
36. P Schlagenhauf, R Steffen, A Tschopp, et al. (1995) Behavioural aspects of travellers in their use of malaria presumptive treatment. Bull World Health Organ 73 215-221.
37. T Jelinek, L Amsler, MP Grobusch, et al. (1999) Self-use of rapid tests for malaria diagnosis by tourists. Lancet 354 1609.
38. CJM Whitty, M Armstrong and RH Behrens (2000) Self-testing for falciparum malaria with antigen-capture cards by travellers with symptoms of malaria. Am J Trop Med Hyg 63 295-297.
39. BP Mulhall (1996) Sex and travel: studies of sexual behaviour, disease and health promotion in international travellers - a global review. Int J STD AIDS 7 455-465.
40. M Bloor, M Thomas, K Hood, et al. (1998) Differences in sexual risk behaviour between young men and women travelling abroad from the UK. Lancet 352 1664-1668.
41. A Eichmann (1993) Sexually transmissible diseases following travel in tropical countries. Schweiz Med Wochenschr 123 1250-1255.
42. L Bonneux, P Van der Stuyft, H Taelman, et al. (1988) Risk factors for infection with human immunodeficiency virus among European expatriates in Africa. BMJ 297 581-584.
43. R de Graaf, G van Zessen, H Houweling, et al. (1997) Sexual risk of HIV infection among expatriates posted in AIDS endemic areas. AIDS 11 1173-1181.
44. D Savarit, KM De Cock, R Schutz, et al. (1992) Risk of HIV infection from transfusion with blood negative for HIV antibody in a west African city. BMJ 305 498-502.
45. M Mutsch, V Spicher, C Gut, et al. (2006) Hepatitis A virus infections in travelers, 1988-2004. Clin Infect Dis 42 490-497.
46. BE Mahon, ED Mintz, KD Greene, et al. (1996) Reported cholera in the United States, 1992-1994: a reflection of global changes in cholera epidemiology. JAMA 276 307-312.
47. JN Zuckerman and R Steffen (2000) Risks of hepatitis B in travellers as compared to immunisation status. J Trav Med 7 170-174.
48. KW Bernard and DB Fishbein (1991) Pre-exposure rabies prophylaxis for travellers: are the benefits worth the cost? Vaccine 9 833-836.
49. AY Khromava, RB Eidex, LH Weld, et al. (2005) Yellow fever vaccine: an updated assessment of advanced age as a risk factor for serious adverse events. Vaccine 23 3256-3263.
50. MK Taha, M Achtman, JM Alonso, et al. (2000) Serogroup W135 meningococcal disease in Hajj pilgrims. Lancet 356 2159.
51. Centers for Disease Control (CDC) (1990) Imported bubonic plague. MMWR Morb Mort Wkly Rep 39 895-901.
52. FG Cobelens, H van Deutekom, IW Draayer-Jansen, et al. (2000) Risk of infection with Mycobacterium tuberculosis in travellers to areas of high tuberculosis endemicity. Lancet 356 461-465.
53. M Moore, SE Valway, W Ihle, et al. (1999) A train passenger with pulmonary tuberculosis: evidence of limited transmission during travel. Clin Infect Dis 28 52-56.
54. M Mutsch, M Tavernini, A Marx, et al. (2005) Influenza virus infection in travelers to tropical and subtropical countries. Clin Infect Dis 40 1282-1287.
55. AR Lifson (2000) Mycobacterium tuberculosis infection in travellers: tuberculosis comes home. Lancet 356 442-443.
56. CJM Whitty, DC Macallan and DJM Lewis (2000) Use of BCG vaccination. Lancet 356 1609-1610.